📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Autonomix

1.1 - Company Overview

Autonomix Logo

Autonomix

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of catheter-based sensing and proprietary ablation technologies that detect, differentiate, and target peripheral neural signals to treat pain or disease, offering an alternative to systemic drugs or blind approaches. Includes a catheter-deployed microchip with basket design converting analog to digital and first-in-class electrophysiology; initial focus on pancreatic cancer pain and minimally invasive renal denervation; supported by 15 patent families and 100+ patents.

Products and services

  • Catheter-based Sensing Technology: Minimally invasive system senses neural signals linked to pain or disease, targets nerves for treatment, offering an alternative to systemic drugs or blind treatment approaches
  • First-in-class Electrophysiology Technology: Based on non-clinical testing, exhibits significantly greater ability to detect and differentiate peripheral neural signals than existing technologies, enhancing diagnostic clarity for targeted interventions
  • Ablation Technology: Proprietary system engineered for safe, effective tissue ablation in disease treatment, with safety demonstrated in animal studies

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Autonomix

Tissuemed Logo

Tissuemed

HQ: United Kingdom Website
  • Description: Provider of tissue-based therapeutic devices and surgical bioadhesive films, including the first tissue heart valve to gain regulatory approval in Europe. Specializes in adhesive films to prevent air, blood and fluid leaks encountered in surgery.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tissuemed company profile →
ArmaGen Logo

ArmaGen

HQ: United States Website
  • Description: Provider of therapies and siRNA delivery technologies that penetrate the blood-brain barrier to treat neurological complications of diseases, including lysosomal storage disorders (LSDs), Alzheimer's and Parkinson's.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ArmaGen company profile →
Kernel Logo

Kernel

HQ: United States Website
  • Description: Provider of non-invasive brain-recording technologies, including Kernel Flow2, a time-domain fNIRS and EEG neuro measurement platform, and Kernel Flow, a multimodal headset combining hemodynamic and EEG data. Services include study design consulting, data management software, custom fNIRS/TD-fNIRS analysis development, and automated quality control metrics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Kernel company profile →
NeuroPace Logo

NeuroPace

HQ: United States Website
  • Description: Provider of implantable neurostimulation devices for neurological disorders, featuring the FDA-approved RNS System for epilepsy to monitor brain activity, detect unusual patterns, and deliver responsive pulses to prevent seizures. Offers personalized neuromodulation based on patient brain activity, the nSight platform for remote data access, and clinical studies (NAUTILUS, RESPONSE, and other RNS System trials).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NeuroPace company profile →
Vigil Neuroscience Logo

Vigil Neuroscience

HQ: United States Website
  • Description: Provider of therapeutics and programs for neurodegenerative diseases, including iluzanebart (a fully human monoclonal antibody targeting TREM2) for ALSP, an oral small molecule TREM2 agonist program for common diseases like Alzheimer's, the ILLUMINATE natural history study and IGNITE Phase 2 trial in ALSP, and the ALSPAware no-cost genetic testing and counseling program.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vigil Neuroscience company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Autonomix

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Autonomix

2.2 - Growth funds investing in similar companies to Autonomix

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Autonomix

4.2 - Public trading comparable groups for Autonomix

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Autonomix

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Autonomix

What does Autonomix do?

Autonomix is a provider of catheter-based sensing and proprietary ablation technologies that detect, differentiate, and target peripheral neural signals to treat pain or disease, offering an alternative to systemic drugs or blind approaches. Includes a catheter-deployed microchip with basket design converting analog to digital and first-in-class electrophysiology; initial focus on pancreatic cancer pain and minimally invasive renal denervation; supported by 15 patent families and 100+ patents.

Who are Autonomix's competitors?

Autonomix's competitors and similar companies include Tissuemed, ArmaGen, Kernel, NeuroPace, and Vigil Neuroscience.

Where is Autonomix headquartered?

Autonomix is headquartered in United States.

How many employees does Autonomix have?

Autonomix has 1,000 employees 🔒.

When was Autonomix founded?

Autonomix was founded in 2010 🔒.

What sector and industry vertical is Autonomix in?

Autonomix is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Autonomix

Who are the top strategic acquirers in Autonomix's sector and industry

Top strategic M&A buyers and acquirers in Autonomix's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Autonomix?

Top strategic M&A buyers groups and sectors for Autonomix include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Autonomix's sector and industry vertical

Which are the top PE firms investing in Autonomix's sector and industry vertical?

Top PE firms investing in Autonomix's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Autonomix's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Autonomix's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Autonomix's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Autonomix include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Autonomix's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Autonomix?

The key public trading comparables and valuation benchmarks for Autonomix include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Autonomix for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Autonomix with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Autonomix's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Autonomix with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Autonomix's' sector and industry vertical?

Access recent funding rounds and capital raises in Autonomix's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Autonomix